NASDAQ:QCOR - Questcor Pharmaceuticals Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileFinancialsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals. Receive QCOR News and Ratings via Email Sign-up to receive the latest news and ratings for QCOR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryPharmaceuticals SectorN/A SymbolNASDAQ:QCOR CUSIP74835Y10 Webwww.mallinckrodt.com Phone+1-714-7864200 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 Questcor Pharmaceuticals (NASDAQ:QCOR) Frequently Asked Questions What is Questcor Pharmaceuticals' stock symbol? Questcor Pharmaceuticals trades on the NASDAQ under the ticker symbol "QCOR." What is the consensus analysts' recommendation for Questcor Pharmaceuticals? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Questcor Pharmaceuticals in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has Questcor Pharmaceuticals been receiving favorable news coverage? Headlines about QCOR stock have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Questcor Pharmaceuticals earned a news sentiment score of 0.04 on Accern's scale. They also gave media headlines about the biopharmaceutical company an impact score of 43.35 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. How do I buy shares of Questcor Pharmaceuticals? Shares of QCOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How can I contact Questcor Pharmaceuticals? Questcor Pharmaceuticals' mailing address is 1300 N Kellogg Dr Ste D, ANAHEIM, CA 92807-1965, United States. The biopharmaceutical company can be reached via phone at +1-714-7864200. MarketBeat Community Rating for Questcor Pharmaceuticals (NASDAQ QCOR)Community Ranking: 3.5 out of 5 ( )Outperform Votes: 293 (Vote Outperform)Underperform Votes: 128 (Vote Underperform)Total Votes: 421MarketBeat's community ratings are surveys of what our community members think about Questcor Pharmaceuticals and other stocks. Vote "Outperform" if you believe QCOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QCOR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?